OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review
Nicola Coley, Caroline Giulioli, Paul Aisen, et al.
Ageing Research Reviews (2022) Vol. 82, pp. 101777-101777
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Gill Livingston, Jonathan Huntley, Kathy Liu, et al.
The Lancet (2024) Vol. 404, Iss. 10452, pp. 572-628
Closed Access | Times Cited: 409

Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults
Kristine Yaffe, Eric Vittinghoff, Sascha Dublin, et al.
JAMA Internal Medicine (2023) Vol. 184, Iss. 1, pp. 54-54
Closed Access | Times Cited: 42

Lifetime risk and projected burden of dementia
Michael Fang, Jiaqi Hu, Jordan Weiss, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 3

An online multidomain lifestyle intervention to prevent cognitive decline in at-risk older adults: a randomized controlled trial
Henry Brodaty, Tiffany Chau, Megan Heffernan, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 1

Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: a secondary analysis of a randomised, controlled, dementia prevention trial
Nicola Coley, Henrik Zetterberg, Christelle Cantet, et al.
The Lancet Healthy Longevity (2024) Vol. 5, Iss. 2, pp. e120-e130
Open Access | Times Cited: 7

Effect of long-term physical exercise and multidomain interventions on cognitive function and the risk of mild cognitive impairment and dementia in older adults: a systematic review with meta-analysis
Imanol Reparaz‐Escudero, Míkel Izquierdo, Heike A. Bischoff‐Ferrari, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102463-102463
Closed Access | Times Cited: 6

Evaluation of efficiency and effectiveness of different recruitment strategies for the FINGER‐NL multidomain lifestyle intervention trial via the Dutch Brain Research Registry
Lisa Waterink, Sietske A.M. Sikkes, Lion M. Soons, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access

Mediation of modifiable risk factors in two multidomain dementia prevention trials
Marieke P. Hoevenaar‐Blom, Jason Shourik, Jan Willem van Dalen, et al.
Alzheimer s & Dementia (2025)
Open Access

Intersectionality in Alzheimer's Disease: The Role of Female Sex and Black American Race in the Development and Prevalence of Alzheimer's Disease
Maria Misiura, Brittany Butts, Bruno L. Hammerschlag, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 1019-1036
Open Access | Times Cited: 14

Modifiable dementia risk factors and AT(N) biomarkers: findings from the EPAD cohort
Eddy Roccati, Aidan Bindoff, Jessica M. Collins, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 4

Tailoring implementation strategies for the healthy actions and lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program: Lessons learned from a survey study
Sara Moukarzel, Carlos Araujo-Menendez, Eliza Galang, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100053-100053
Open Access

Adherence and intensity in multimodal lifestyle-based interventions for cognitive decline prevention: state-of-the-art and future directions
Natalia Soldevila‐Domenech, Amaia Ayala‐García, Mariagnese Barbera, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access

Breakdown and repair of metabolism in the aging brain
Polina Shichkova, Jay S. Coggan, Lida Kanari, et al.
Frontiers in Science (2025) Vol. 3
Open Access

Exercise as medicine for the brain: moving towards precise and personalised recommendations
Patricio Solis‐Urra, Beatriz Fernandez‐Gamez, Teresa Liu‐Ambrose, et al.
British Journal of Sports Medicine (2024) Vol. 58, Iss. 13, pp. 693-695
Closed Access | Times Cited: 3

How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer’s disease?
J. M. R. Beveridge, Eileen Kaniecki, Aniketh Naidu, et al.
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 1, pp. 35-43
Closed Access | Times Cited: 2

Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement
Cristina Popescu, Constantin Munteanu, Aurelian Anghelescu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11272-11272
Open Access | Times Cited: 2

How Modifiable Are Modifiable Dementia Risk Factors? A Framework for Considering the Modifiability of Dementia Risk Factors
Lisa Bransby, Emily Rosenich, Paul Maruff, et al.
The Journal of Prevention of Alzheimer s Disease (2023)
Open Access | Times Cited: 6

Resistance Exercise Program in Cognitively Normal Older Adults: CERT-Based Exercise Protocol of the AGUEDA Randomized Controlled Trial
Beatriz Fernandez‐Gamez, Patricio Solis‐Urra, Marcos Olvera‐Rojas, et al.
The journal of nutrition health & aging (2023) Vol. 27, Iss. 10, pp. 885-893
Open Access | Times Cited: 4

The magnitude and direction of the relationship between risk factor and cognition depends on age: a pooled analysis of 5 community-based studies
Osorio Meirelles, Anthony Arnette, Vilmundur Guðnason, et al.
European Journal of Epidemiology (2024) Vol. 39, Iss. 2, pp. 161-169
Open Access | Times Cited: 1

Resolving a paradox: antidepressants, neuroinflammation, and neurodegeneration
Ravi Philip Rajkumar
Exploration of Neuroprotective Therapy (2024), pp. 11-37
Open Access | Times Cited: 1

Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidance
Leanne Howard, Carla Abdelnour, Erin L. Abner, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 7, pp. 4625-4634
Open Access | Times Cited: 1

Fostering healthy cognitive ageing in people living with HIV
Lucette A. Cysique, Jules Levin, Chris Howard, et al.
The Lancet HIV (2024) Vol. 12, Iss. 1, pp. e71-e80
Closed Access | Times Cited: 1

Healthy lifestyle and cognitive aging: What is the gap behind prescribing healthier lifestyle?
José M. Aravena
Alzheimer s & Dementia (2023) Vol. 19, Iss. 7, pp. 3233-3234
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top